These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37802276)

  • 1. A multi-functional drug delivery nanosystem release of TLR-7 immunostimulant and OKT3 induced efficient cancer immunotherapy.
    Li R; Huang X; Li X; Liu H; Zhou J; Shen J
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103834. PubMed ID: 37802276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CaCO
    Li R; Shi X; Zhang J; Liu B; Shen J; Liu H; Zhou J
    Heliyon; 2024 Jul; 10(13):e33837. PubMed ID: 39050425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dual Functional Drug Delivery System that Combines Photothermal Therapy and Immunotherapy to Treat Tumors.
    Li R; Zheng Q; Deng Q; Wang Y; Yang H; Shen J; Liu Y; Zhou J
    Mol Pharm; 2022 May; 19(5):1449-1457. PubMed ID: 35388697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamic therapeutic effect of a targeted photothermal nanovaccine incorporating toll-like receptor 7 agonist enhanced cancer immunotherapy.
    Karthikeyan L; Rithisa B; Vivek R
    J Mater Chem B; 2023 Sep; 11(37):9005-9018. PubMed ID: 37712149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
    Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles.
    Bocanegra Gondan AI; Ruiz-de-Angulo A; Zabaleta A; Gómez Blanco N; Cobaleda-Siles BM; García-Granda MJ; Padro D; Llop J; Arnaiz B; Gato M; Escors D; Mareque-Rivas JC
    Biomaterials; 2018 Jul; 170():95-115. PubMed ID: 29656235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen.
    Al Fayez N; Rouhollahi E; Ong CY; Wu J; Nguyen A; Böttger R; Cullis PR; Witzigmann D; Li SD
    J Control Release; 2022 Oct; 350():630-641. PubMed ID: 36058352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
    Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
    ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
    Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
    J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-Gradient-Driven Porphyrin-Based Liposome Remote-Loaded with Imiquimod as In Situ Nanoadjuvants for Synergistically Augmented Tumor Photoimmunotherapy.
    Liu D; Fu L; Gong L; Li S; Li K; Liu K; Yang D
    ACS Appl Mater Interfaces; 2024 Feb; 16(7):8403-8416. PubMed ID: 38334116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy.
    Yasothamani V; Vivek R
    J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Activatable Dual Polymer Nanosystem for Photoimmunotherapy and Metabolic Modulation of Deep-Seated Tumors.
    Liu G; Li J; Wang X; Ren H; Zhang Y
    Adv Healthc Mater; 2024 Apr; 13(9):e2303305. PubMed ID: 38277491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment.
    Nguyen BL; Phung CD; Pham DV; Le ND; Jeong JH; Kim J; Kim JH; Chang JH; Jin SG; Choi HG; Ku SK; Kim JO
    J Control Release; 2023 Sep; 361():443-454. PubMed ID: 37558053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coat.
    Nkanga CI; Ortega-Rivera OA; Steinmetz NF
    Nanomedicine; 2022 Aug; 44():102573. PubMed ID: 35728739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer.
    Chang R; Chu X; Zhang J; Fu R; Feng C; Jia D; Wang R; Yan H; Li G; Li J
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue.
    Corogeanu D; Zaki K; Beavil AJ; Arnold JN; Diebold SS
    PLoS One; 2023; 18(3):e0282831. PubMed ID: 36913398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment.
    Shen N; Wu J; Yang C; Yu H; Yang S; Li T; Chen J; Tang Z; Chen X
    Nano Lett; 2019 Nov; 19(11):8021-8031. PubMed ID: 31558024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulator-Mediated Suppressive Tumor Immune Microenvironment Remodeling Nanoplatform for Enhanced Immuno/Chemo/Photothermal Combination Therapy of Triple Negative Breast Cancer.
    Wang A; Yang X; Li R; Shao L; Zhao W; Hu X; Fang K; Chai K; Shi S; Dong C
    ACS Appl Mater Interfaces; 2023 Nov; 15(46):53318-53332. PubMed ID: 37943829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.